These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8898976)

  • 1. Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines--with special reference to cisplatin.
    Bernges F; Zeller WJ
    J Cancer Res Clin Oncol; 1996; 122(11):665-70. PubMed ID: 8898976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased poly(ADP-ribose) formation in cisplatin-resistant rat ovarian tumor cells.
    Chen G; Zeller WJ
    Anticancer Res; 1994; 14(4A):1461-7. PubMed ID: 7979172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional overexpression of human poly(ADP-ribose) polymerase in transfected rat tumor cells.
    Bernges F; Bürkle A; Küpper JH; Zeller WJ
    Carcinogenesis; 1997 Apr; 18(4):663-8. PubMed ID: 9111197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines.
    Chen G; Zeller WJ
    Cancer Lett; 1992 Oct; 67(1):27-33. PubMed ID: 1423242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(ADP-ribose) polymerase-independent potentiation of nitrosourea cytotoxicity by 3-aminobenzamide in human malignant glioma cells.
    Winter S; Weller M
    Eur J Pharmacol; 2000 Jun; 398(2):177-83. PubMed ID: 10854828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo.
    Chen G; Zeller WJ
    Cancer Chemother Pharmacol; 1990; 26(1):37-41. PubMed ID: 2322989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
    Wedge SR; Porteous JK; Newlands ES
    Br J Cancer; 1996 Oct; 74(7):1030-6. PubMed ID: 8855970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of O6-alkylguanine-DNA alkyltransferase in animal and human ovarian tumor cell lines by O6-benzylguanine and sensitization to BCNU.
    Magull-Seltenreich A; Zeller WJ
    Cancer Chemother Pharmacol; 1995; 35(3):262-6. PubMed ID: 7805187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells].
    Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY
    Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thaliblastine on cytotoxicity and DNA damage in drug-sensitive and -resistant rat ovarian tumor cells treated with cisplatin.
    Chen G; Zeller WJ
    Anticancer Res; 1993; 13(1):219-23. PubMed ID: 8476216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin.
    Masanek U; Stammler G; Volm M
    Anticancer Drugs; 1997 Feb; 8(2):189-98. PubMed ID: 9073315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of bleomycin activity by 3-aminobenzamide, a poly (ADP-ribose) synthesis inhibitor, in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M
    Anticancer Res; 1988; 8(2):239-43. PubMed ID: 2452600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.
    Chen G; Zeller WJ
    J Cancer Res Clin Oncol; 1990; 116(5):443-7. PubMed ID: 2121738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of acquired cisplatin resistance by nicotinamide in vitro and in vivo.
    Chen G; Zeller WJ
    Cancer Chemother Pharmacol; 1993; 33(2):157-62. PubMed ID: 8261576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of N-methyl-N'-nitro-N-nitrosoguanidine-induced O6-methylguanine-DNA-methyltransferase activity in a rat hepatoma cell line by poly (ADP-ribose) synthesis inhibitors.
    Lefebvre P; Laval F
    Biochem Biophys Res Commun; 1989 Aug; 163(1):599-604. PubMed ID: 2505771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation.
    Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA
    Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13* cells.
    Zhang J; Kan Y; Tian Y; Wang Z; Zhang J
    Indian J Med Res; 2013 Mar; 137(3):527-32. PubMed ID: 23640560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of carcinogen-induced methotrexate resistance and dihydrofolate reductase gene amplification by inhibitors of poly(adenosine diphosphate-ribose) polymerase.
    Bürkle A; Heilbronn R; zur Hausen H
    Cancer Res; 1990 Sep; 50(18):5756-60. PubMed ID: 2118419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.